These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Evidence for the influence of euglycemia on diabetic microangiopathy. Federlin K; Bretzel RG; Manns E Horm Metab Res Suppl; 1979; (8):8-15. PubMed ID: 119700 [No Abstract] [Full Text] [Related]
27. KK mouse. Ikeda H Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S313-6. PubMed ID: 7859626 [TBL] [Abstract][Full Text] [Related]
28. Sequence of changes in KK mouse nephropathy. Wehner H Adv Exp Med Biol; 1988; 246():147-56. PubMed ID: 3250252 [No Abstract] [Full Text] [Related]
30. Hyperglycemia and microangiopathy. Direct regulation by glucose of microvascular cells. Kreisberg JI Lab Invest; 1992 Oct; 67(4):416-26. PubMed ID: 1434526 [No Abstract] [Full Text] [Related]
31. Diabetic regulation and its relationship to microangiopathy. Raskin P Metabolism; 1978 Feb; 27(2):235-52. PubMed ID: 340847 [TBL] [Abstract][Full Text] [Related]
32. Studies in the diabetic mutant mouse. V. Glucose tolerance in mice homozygous and heterozygous for the diabetes (db) gene. Chick WL; Lavine RL; Like AA Diabetologia; 1970 Jun; 6(3):257-62. PubMed ID: 5432354 [No Abstract] [Full Text] [Related]
33. Arginine reduces kidney collagen accumulation, cross-linking, lipid peroxidation, glycoxidation, kidney weight and albuminuria in the diabetic kk mouse. Lubec B; Aufricht C; Amann G; Kitzmüller E; Höger H Nephron; 1997; 75(2):213-8. PubMed ID: 9041544 [TBL] [Abstract][Full Text] [Related]
34. Anti-diabetic effects of globin digest and its active ingredient Leu-Ser-Glu-Leu in ICR mice, streptozotocin-induced diabetic mice and KK-Ay mice. Nakaoka F; Sasakawa Y; Yamamoto K; Nakao M; Nakamura M; Tong C; Fukuhama C; Kagawa K Life Sci; 2010 Mar; 86(11-12):424-34. PubMed ID: 20109472 [TBL] [Abstract][Full Text] [Related]
35. Microangiopathy in the experimentally diabetic animal. Bloodworth JM; Engerman RL; Anderson PJ Adv Metab Disord; 1973; 2():Suppl 2:245-50. PubMed ID: 4198283 [No Abstract] [Full Text] [Related]
37. Diabetic nephropathy as the mode of presentation of diabetes mellitus. Winaver J; Teredesai P; Feldman HA; Stachura I; Cavallo T; Puschett JB Metabolism; 1979 Oct; 28(10):1023-30. PubMed ID: 491959 [TBL] [Abstract][Full Text] [Related]
38. Hyperglycemia and hyperlipidemia act synergistically to induce renal disease in LDL receptor-deficient BALB mice. Spencer MW; Mühlfeld AS; Segerer S; Hudkins KL; Kirk E; LeBoeuf RC; Alpers CE Am J Nephrol; 2004; 24(1):20-31. PubMed ID: 14671436 [TBL] [Abstract][Full Text] [Related]
39. Morphological characterization of systemic changes in KK-Ay mice as an animal model of type 2 diabetes. Moroki T; Yoshikawa Y; Yoshizawa K; Tsubura A; Yasui H In Vivo; 2013; 27(4):465-72. PubMed ID: 23812216 [TBL] [Abstract][Full Text] [Related]
40. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. The mesangial regions. Rasch R Diabetologia; 1979 Oct; 17(4):243-8. PubMed ID: 499683 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]